UK MHRA Acts To Improve Quality Of GCP Serious Breach Reports
Patient Safety The Main Cause Of Notifications In 2019
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency has issued updated guidance and application form to help clinical trial sponsors provide better information on reports of serious breaches, which in turn would support the agency in assessing the issue.